/Investor DB

Red Cell Incubation — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Zephyr AIzephyrai.bioin𝕏Mar 2024

Zephyr AI is a healthcare technology company.

AI & Machine LearningBiotechDigital HealthDallas, US

Grant Verstandig(Director)inYisroel Brumer(Director)Jeff Sherman(Executive Officer)David Morgan(Executive Officer)Ken Samet(Director)Sol Barer(Director)

Board seatGrant VerstandigYisroel BrumerRoger Ferguson, Jr.· per SEC Form D

Co-investorsMerck Global Health Innovation FundMSD Global Health Innovation FundRevolutionMedicxi

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.